Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Details 詳細情報について

• CRID

  1362544421334024832

• DOI

  10.1016/s1470-2045(13)70181-5

• ISSN

  14702045

• Web Site

  https://api.elsevier.com/content/article/PII:S1470204513701815?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1470204513701815?httpAccept=text/plain

• Data Source

  • Crossref